Skinvisible, Inc. SKVI Archives - Page 4 of 4

WednesdayNov 08, 2017 1:16 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Develops Hemp-based Products with an Enhanced Delivery System

Skinvisible, Inc.’s (OTCQB: SKVI) proprietary topical drug delivery technology, Invisicare®, improves the delivery of pharmaceutical and medicinal compounds to and through the skin. The company develops hemp-based products and recently expanded its product line to the enter the cannabis-based topical product market. An article discussing this reads: “The patented polymer technology has been used in cosmeceutical, over-the-counter and pharmaceutical products for nearly two decades. On September 28, 2017, Skinvisible signed an exclusive agreement with Canopy Growth Corporation for the purpose of increasing its reach to Canada and establishing its position on the cannabis product markets. The definitive licensing agreement for…

MondayNov 06, 2017 3:18 pm

Skinvisible, Inc.’s (SKVI) Patented Polymer Delivery Technology Could Take CBD Products to the Next Level

Skinvisible already develops hemp-based products and is expanding its product line of cannabis-based topical product market Research verifies its Invisicare® technology improves the penetration rate and boosts the availability of the cannabis ingredients in both topical and transdermal products Skinvisible has entered a strategic partnership with Canopy Growth Corporation for the sale of its product formulations in the Canadian market Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. (OTCQB: SKVI), has a potentially wide range of applications in the cannabis market. The technology improves the delivery of pharmaceutical and medicinal compounds to and through the skin, which…

FridayNov 03, 2017 12:31 pm

QualityStocksNewsBreaks – Skinvisible, Inc.’s (SKVI) Invisicare Technology Tackles Dermatology, CBD Markets

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has developed Invisicare® technology, a patented polymer delivery system that improves the delivery of topically applied skin care products by enhancing the effectiveness of the active ingredients. Skinvisible out-licenses its formulations, enabling companies like Canopy Hemp Corporation to bring their own patented products to market and combat generic competitors. An article discussing this reads: “With a $80 billion global dermatology market and a $30 billion global skin care over-the-counter (OTC) market, the patented polymer delivery system for topical products developed by Skinvisible, obviously, has many, many possible applications. The company has already…

ThursdayOct 26, 2017 12:03 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at the Global Skincare Market

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products. An article discussing this reads: “Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market that's projected to reach $135 billion by 2021 (http://dtn.fm/jWU5t). SKVI also sees a worldwide dermatology market of $80 billion, plus a $30 billion worldwide over-the-counter (OTC) market (http://dtn.fm/f7WkB). It has already completed the development of 40 products, received numerous technology and product patents and is now ready to monetize its investment. In the U.S. alone, skincare is projected to reach $10.7 billion…

TuesdayOct 24, 2017 11:36 am

Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021

Owns patented Invisicare® polymer delivery system, prescription and over-the-counter skincare products formulated with Invisicare Business model to grow globally by out-licensing its proprietary and patented product line Developed multiple cannabis-based products with CBD from imported hemp (non-psychoactive), and will continue to develop line utilizing CBD and THC from marijuana Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market projected to reach $135 billion by 2021 (http://dtn.fm/xEK9T). SKVI also sees a worldwide dermatology market now of $80 billion plus a $30 billion worldwide over-the-counter (OTC) market (http://dtn.fm/mBU1s). It has already completed on the development of 40 products, received numerous technology…

MondayOct 16, 2017 2:08 pm

Skinvisible, Inc. (SKVI) Has Been Delivering its Patented Polymer Technology to Pharmaceuticals & Cosmeceuticals for Close to Two Decades

Topical product technology protected by patents Targeting $80 billion global skin care and dermatology market Product sales in China Outsourcing has been the status quo in the pharmaceutical industry since long before the term gained notoriety. Large pharmaceutical and cosmeceutical companies, under pressure from rising R&D costs, have been farming out that part of their businesses for a long time now in an attempt to reduce costs. This approach also has the advantage of offloading the costs of patenting to the outsourcee. To obtain the advantages of adopting new technology, patent protection is vital to avoid copycatting. That is why…

ThursdayOct 12, 2017 2:27 pm

QualityStocksNewsBreaks – Why Skinvisible, Inc. (SKVI) is Worth Watching in a $65B Market

Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is an R&D company offering its patented Invisicare® technology, which can be used to revitalize or create new medical or skincare products, thus enabling companies that license Skinvisible’s formulations to sell their own patented products and ward off generic rivals. A high-performance topical and transdermal delivery system, Invisicare enhances the delivery of drugs and other ingredients to and through the skin utilizing Skinvisible’s innovative formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. An article discussing this reads: “A prescription dermatology product…

FridayOct 06, 2017 12:53 pm

Skinvisible, Inc. (SKVI) is “One to Watch”

Patented technology enhances how topical and transdermal drugs and skin care products are delivered Polymer delivery vehicle can be tailored to almost any type of molecule including the medicinal components of hemp and marijuana 14 patents granted in the U.S. and internationally $65 billion market in dermatology, pharmaceutical and other healthcare industries offers strong growth opportunity Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible’s formulations to sell their…

Site Search

Company Search

Tag: Skinvisible, Inc. SKVI